Get the Stockscreener App
17.85
1.27%
-0.23
After Hours:
17.82
-0.03
-0.17%
Staar Surgical Co stock is traded at $17.85, with a volume of 852.21K.
It is down -1.27% in the last 24 hours and up +10.19% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
See More
Previous Close:
$18.08
Open:
$18.05
24h Volume:
852.21K
Relative Volume:
0.57
Market Cap:
$883.80M
Revenue:
$239.44M
Net Income/Loss:
$-80.45M
P/E Ratio:
-10.95
EPS:
-1.6303
Net Cash Flow:
$-40.05M
1W Performance:
+3.60%
1M Performance:
+10.19%
6M Performance:
-34.28%
1Y Performance:
+1.33%
1-Day Range:
$17.59
$18.20
1-Week Range:
$17.03
$19.36
52-Week Range:
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
17.85 | 895.19M | 239.44M | -80.45M | -40.05M | -1.6303 |
|
ISRG
Intuitive Surgical Inc
|
482.76 | 171.69B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
161.64 | 45.59B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.78 | 37.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.16 | 33.89B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
233.50 | 33.59B | 5.40B | 1.49B | 1.78B | 10.12 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-26 | Initiated | Wedbush | Neutral |
| Jan-16-26 | Resumed | Morgan Stanley | Underweight |
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
The Chart That Says You're Right on STAAR Surgical - AOL.com
Insider Buying: STAAR Surgical (NASDAQ:STAA) Director Acquires 54,764 Shares of Stock - MarketBeat
STAAR Surgical (NASDAQ:STAA) Director Broadwood Partners, L.P. Purchases 316,017 Shares - MarketBeat
Broadwood boosts STAAR Surgical (STAA) stake with 670K-share open-market buys - Stock Titan
Broadwood group (NASDAQ: STAA) reports 32.6% STAAR Surgical stake - Stock Titan
Midday Stock Roundup: Veritone Down 5% After Delaying Q4, FY Earnings - Orange County Business Journal
Refractive Vision Correction Market is expected to hit US$ 8.53 - openPR.com
Director at STAAR Surgical (STAA) receives 7,524 long-dated options - Stock Titan
Director at STAAR Surgical (STAA) receives grant of 7,524 stock options - Stock Titan
Canaccord reiterates Hold on STAAR Surgical stock, $22 target - Investing.com Nigeria
Stifel cuts Staar Surgical stock price target on weak Q4 results - Investing.com Nigeria
Staar Surgical taps Amico Group as Middle East distributor - Arab News PK
STAAR Surgical Co. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
STAAR Surgical Co. Experiences Evaluation Revision Amidst Fluctuating Market Conditions - Markets Mojo
GABELLI & Co INVESTMENT ADVISERS INC. Makes New $4.81 Million Investment in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical net loss hits USD 18.3M in Q4 2025 - Medical Buyer
STAA: Wells Fargo Lowers Price Target by 47.97% on Staar Surgica - GuruFocus
Wells Fargo & Company Cuts STAAR Surgical (NASDAQ:STAA) Price Target to $16.00 - MarketBeat
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 Earnings Call Transcript - Insider Monkey
STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives - simplywall.st
STAAR Surgical Releases Q4 and Full Year 2025 Financial Results - VisionMonday.com
Canaccord reiterates Hold on STAAR Surgical stock, $22 target By Investing.com - Investing.com Canada
Needham maintains Hold on STAAR Surgical stock after Q4 miss - Investing.com Nigeria
Staar Surgical Posts Q4 Loss After Rejecting Alcon Deal - Medical Device and Diagnostic industry
STAAR Surgical Q4 2025 Earnings Report: Revenue Growth & Analyst OutlookNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
STAAR Surgical (NASDAQ:STAA) Shares Gap Down Following Weak Earnings - MarketBeat
Staar Surgical Q4 2025 Earnings: Revenue and Earnings Miss EstimatesNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
STAA Analyst Rating Update: Stifel Lowers Price Target | STAA St - GuruFocus
Stifel Nicolaus Issues Pessimistic Forecast for STAAR Surgical (NASDAQ:STAA) Stock Price - MarketBeat
A Glimpse Into The Expert Outlook On Staar Surgical Through 7 Analysts - Benzinga
STAAR Surgical Company Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
STAAR Surgical earnings missed by $0.52, revenue topped estimates - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2% - The Globe and Mail
Staar Surgical Co (STAA) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
STAAR Surgical Q4 2025 Earnings Call Transcript - MarketBeat
STAAR Surgical Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: STAAR Surgical Q4 2025 misses EPS forecast, stock dips - Investing.com Nigeria
Staar Surgical co-CEOs address shareholders, poor Q4 earnings - MassDevice
STAAR Surgical names interim co-CEOs, targets 2026 growth - Investing.com Australia
STAA Reports Lower Q4 Revenue Amidst Inventory Adjustments and M - GuruFocus
STAAR Surgical stock plunges 12% on unexpected Q4 loss By Investing.com - Investing.com Canada
Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates - Yahoo Finance UK
STAAR Surgical Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (STAA) STAAR Surgical Posts Q4 Loss of $0.37, vs. FactSet Est EPS of $0.04 - marketscreener.com
STAAR Surgical names interim co-CEOs, targets 2026 growth By Investing.com - Investing.com India
STAAR Surgical stock plunges 12% on unexpected Q4 loss - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Issues Earnings Results - MarketBeat
Staar Surgical: Q4 Earnings Snapshot - Bitget
Staar Surgical reports Q4 EPS 0c, consensus 17c - TipRanks
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):